Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
NCT06012500
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
ILD
Interventions
DRUG:
Xenon-129
Sponsor
Children's Hospital Medical Center, Cincinnati